Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1

4(80.0%)

N/A

1(20.0%)

5Total

Phase 1(4)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06234657Not ApplicableRecruiting

Effectiveness of Telerehabilitation on the Performance of Post-stroke Patients' Daily Living Activities and Evaluation of Satisfaction in Post-stroke Patients in Vietnam

Role: lead

NCT05827757Phase 1Unknown

Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.

Role: collaborator

NCT03484741Phase 1Unknown

Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients

Role: collaborator

NCT02142842Phase 1Completed

Autologous Adipose Stem Cells and Platelet Rich Plasma Therapy for Patients With Knee Osteoarthritis

Role: lead

NCT02645305Phase 1Unknown

Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease

Role: lead

All 5 trials loaded